Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Plasma levels of glucagon but not GLP-1 are elevated in response to inflammation in humans

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Cholecystokinin and the hormone concept

    Publikation: Bidrag til tidsskriftReviewpeer review

  2. Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Free testosterone and cardiometabolic parameters in men: comparison of algorithms

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-term outcomes in young patients with atrioventricular block of unknown aetiology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The evolution of the neonatal QRS axis during the first four weeks of life

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Genetic insight into sick sinus syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: Glucagon and glucagon-like peptide-1 (GLP-1) originate from the common precursor, proglucagon, and their plasma concentrations have been reported to be increased during inflammatory conditions. Increased blood glucose levels are frequently observed in septic patients, and therefore we hypothesized that glucagon, but not GLP-1, is increased in individuals with inflammation.

DESIGN: Prospective longitudinal cohort study.

MATERIALS AND METHODS: We measured glucagon and GLP-1 in plasma sampled consecutively in three cohorts consisting of patients with infective endocarditis (n=16), urosepsis (n=28) and post-operative inflammation following percutaneous aortic valve implantation or thoracic endovascular aortic repair (n=5). Correlations between C-Reactive Protein (CRP), a marker of systemic inflammation, and glucagon and GLP-1 concentrations were investigated. Additionally, glucagon and GLP-1 concentrations were measured after a bolus infusion of lipopolysaccharide (LPS, 1ng/kg) in nine healthy young males.

RESULTS: Glucagon and CRP were positively and significantly correlated (r=0.27; P=0.0003), whereas no significant association between GLP-1 and CRP was found (r=0.08, P=0.30). LPS infusion resulted in acute systemic inflammation reflected by increased temperature, pulse, tumor necrosis factor-α (TNFα), interleukin-6 (IL-6) and concomitantly increased concentrations of glucagon (P<0.05) but not GLP-1.

CONCLUSIONS: Systemic inflammation caused by bacterial infections or developed as a non-infected condition is associated with increased plasma concentration of glucagon, but not GLP-1. Hyperglucagonemia may contribute to the impaired glucose control in patients with systemic inflammatory diseases.

OriginalsprogEngelsk
TidsskriftEndocrine Connections
Vol/bind10
Udgave nummer2
Sider (fra-til)205-213
Antal sider9
ISSN2049-3614
DOI
StatusUdgivet - feb. 2021

ID: 62374897